Keystone Symposia: Diabetes

The increased incidence of Type 2 diabetes
mellitus is a growing threat to global health. This chronic and
progressive metabolic disease is characterized by insulin resistance and
beta cell defects, arising from environmental and genetic factors.
Multi-disciplinary approaches that capitalize on genetic, genomic and
physiological disciplines are required to gain insight into Type 2
diabetes pathogenesis through an increased understanding of the
complicated biology that contributes to the development of insulin
resistance and beta cell failure. The meeting will focus on latest
advancements in our understanding of the molecular pathogenesis of Type 2
diabetes to accelerate the translation of experimental and clinical
discoveries to link phenotype to genotype. Particular emphasis will be
placed on 1) epigenetics, genetics and pharmacogenomics of metabolic
responses, 2) links between pathways linking obesity, inflammation, and
insulin resistance and 3) Type 2 diabetes in children and adolescents. A
key goal for the meeting will be to facilitate collaborative
interactions between basic and clinical scientists focused on
prediction, prevention, and treatment of insulin resistance and
diabetes.

When is Keystone Symposia: Diabetes?

The next dates haven't been confirmed. The last edition we have on record was 12–17 Apr 2010.

Where is it held?

The last edition we have was at TELUS Whistler Conference Centre, Whistler, Canada.